Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Sell
47
ZBH Quote, Financials, Valuation and Earnings
Last price:
$94.26
Seasonality move
:
7.29%
Day range:
$93.23 - $94.76
52-week range:
$85.33 - $114.44
Dividend yield:
1.02%
P/E ratio:
23.33x
P/S ratio:
2.34x
P/B ratio:
1.46x
Volume:
2.3M
Avg. volume:
2.3M
1-year change:
-13.63%
Market cap:
$18.7B
Revenue:
$7.7B
EPS (TTM):
$4.04
Analysts' Opinion
-
Consensus RatingZimmer Biomet Holdings, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 17 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $102.92, Zimmer Biomet Holdings, Inc. has an estimated upside of 9.16% from its current price of $94.28.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $88.00 representing 100% downside risk from its current price of $94.28.
Fair Value
-
According to the consensus of 23 analysts, Zimmer Biomet Holdings, Inc. has 9.16% upside to fair value with a price target of $102.92 per share.
ZBH vs. S&P 500
-
Over the past 5 trading days, Zimmer Biomet Holdings, Inc. has underperformed the S&P 500 by -3.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Zimmer Biomet Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Zimmer Biomet Holdings, Inc. has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Zimmer Biomet Holdings, Inc. reported revenues of $2B.
Earnings Growth
-
Zimmer Biomet Holdings, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Zimmer Biomet Holdings, Inc. reported earnings per share of $1.16.
Enterprise value:
25.5B
EV / Invested capital:
1.22x
Price / LTM sales:
2.34x
EV / EBIT:
17.32x
EV / Revenue:
3.18x
PEG ratio (5yr expected):
0.15x
EV / Free cash flow:
22.56x
Price / Operating cash flow:
16.60x
Enterprise value / EBITDA:
10.02x
Gross Profit (TTM):
$5B
Return On Assets:
3.62%
Net Income Margin (TTM):
10.08%
Return On Equity:
6.45%
Return On Invested Capital:
4.11%
Operating Margin:
16.52%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $7.3B | $7.6B | $8B | $1.8B | $2B | |
| Gross Profit | $4.6B | $4.8B | $5B | $1.2B | $1.3B | |
| Operating Income | $1.3B | $1.4B | $1.5B | $360.6M | $330.7M | |
| EBITDA | $2.2B | $2.4B | $2.5B | $611.5M | $614.3M | |
| Diluted EPS | $2.26 | $5.25 | $4.04 | $1.23 | $1.16 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.3B | $4.5B | $4.4B | $4.9B | $5.8B | |
| Total Assets | $24B | $21.3B | $21.2B | $21.7B | $23.5B | |
| Current Liabilities | $2.9B | $2.3B | $2.1B | $3.6B | $2.4B | |
| Total Liabilities | $11.3B | $9.1B | $8.7B | $9.3B | $10.7B | |
| Total Equity | $12.7B | $12.3B | $12.5B | $12.4B | $12.8B | |
| Total Debt | $7.5B | $5.7B | $5.5B | $6.5B | $8.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.2B | $1.6B | $1.7B | $395.7M | $418.7M | |
| Cash From Investing | -$670.6M | -$817.7M | -$1.9B | -$154.9M | -$163.3M | |
| Cash From Financing | -$825.5M | -$495.3M | $982.4M | -$101.9M | $483.8M | |
| Free Cash Flow | $559.2M | $979.5M | $1.1B | $190.4M | $267.7M | |
ZBH
Sector
Market Cap
$18.7B
$28.5M
Price % of 52-Week High
82.38%
51.44%
Dividend Yield
1.02%
0%
Shareholder Yield
0.03%
-1.33%
1-Year Price Total Return
-13.63%
-20.32%
Beta (5-Year)
0.615
0.520
Dividend yield:
1.02%
Annualized payout:
$0.96
Payout ratio:
20.66%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$95.20
200-day SMA
Sell
Level
$98.93
Bollinger Bands (100)
Sell
Level
93 - 103.58
Chaikin Money Flow
Sell
Level
-357.3K
20-day SMA
Buy
Level
$91.99
Relative Strength Index (RSI14)
Sell
Level
49.95
ADX Line
Buy
Level
37.06
Williams %R
Neutral
Level
-41.2183
50-day SMA
Sell
Level
$96.31
MACD (12, 26)
Buy
Level
19.28
25-day Aroon Oscillator
Sell
Level
-8
On Balance Volume
Neutral
Level
5.4M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8599)
Buy
CA Score
(Annual)
Level (0.3642)
Buy
Beneish M-Score
(Annual)
Level (-2.5965)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-1.6482)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Stock Forecast FAQ
In the current month, ZBH has received 5 Buy ratings 17 Hold ratings, and 1 Sell ratings. The ZBH average analyst price target in the past 3 months is $102.92.
-
Where Will Zimmer Biomet Holdings, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Zimmer Biomet Holdings, Inc. share price will rise to $102.92 per share over the next 12 months.
-
What Do Analysts Say About Zimmer Biomet Holdings, Inc.?
Analysts are divided on their view about Zimmer Biomet Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Zimmer Biomet Holdings, Inc. is a Sell and believe this share price will drop from its current level to $88.00.
-
What Is Zimmer Biomet Holdings, Inc.'s Price Target?
The price target for Zimmer Biomet Holdings, Inc. over the next 1-year time period is forecast to be $102.92 according to 23 Wall Street analysts, 5 of them rate the stock a Buy, 1 rates the stock a Sell, and 17 analysts rate the stock a Hold.
-
Is ZBH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Zimmer Biomet Holdings, Inc. is a Hold. 17 of 23 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ZBH?
You can purchase shares of Zimmer Biomet Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Zimmer Biomet Holdings, Inc. shares.
-
What Is The Zimmer Biomet Holdings, Inc. Share Price Today?
Zimmer Biomet Holdings, Inc. was last trading at $94.26 per share. This represents the most recent stock quote for Zimmer Biomet Holdings, Inc.. Yesterday, Zimmer Biomet Holdings, Inc. closed at $94.28 per share.
-
How To Buy Zimmer Biomet Holdings, Inc. Stock Online?
In order to purchase Zimmer Biomet Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ZBH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZBH
Sector
P/E ratio
23.33x
23.75x
PEG ratio
0.15x
-0.01x
P/B ratio
1.46x
1.83x
Price / LTM sales
2.34x
1.60x
Growth Metrics
ZBH
Sector
Revenue growth
9.71%
4.85%
Earnings growth
-5.35%
11.11%
Revenue (5-year growth)
-0.77%
6.45%
Earnings forecast
$1.87
-$0.20
Profitability
ZBH
Sector
Profitability FY 2024
$4.8B
$3.6M
Return on invested capital
4.11%
-30.98%
Return on assets
3.62%
-27.62%
Return on equity
6.45%
-36.69%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
4
Balance Sheet
ZBH
Sector
Total cash
$1.3B
$27.2M
Short term investments
--
$25.7M
Total assets
$21.4B
$79.7M
Long term debt
$8.1B
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
